LifeVantage (LFVN) Stock Chart & Stock Price History $13.00 +0.78 (+6.38%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends LifeVantage Stock Price Performance5 Day Performance-7.74%1 Month Performance+5.43%3 Month Performance+61.09%6 Month Performance+110.36%Year-To-Date Performance+116.67%1 Year Performance+71.96% Receive LFVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Opportunistic TraderMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...For a limited time, he's revealing his latest forecast here. LFVN Stock Chart for Saturday, November, 2, 2024 LFVN Chart by TradingView LifeVantage Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$12.22$13.00+6.38%$13.10$12.2661,239 shs$162.76 million10/31/2024$12.93$12.22-5.49%$13.61$11.8777,354 shs$155.21 million10/30/2024$12.98$12.93-0.39%$13.29$10.83228,284 shs$164.22 million10/29/2024$13.49$12.98-3.78%$13.69$12.74172,827 shs$164.86 million10/28/2024$14.09$13.49-4.26%$14.50$13.26181,150 shs$171.34 million10/25/2024$12.98$14.09+8.55%$14.71$13.43284,986 shs$175.84 million Get the Latest News and Ratings for LFVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$12.52$12.98+3.67%$13.20$12.51181,132 shs$164.86 million10/23/2024$12.43$12.52+0.72%$12.65$12.0174,888 shs$159.02 million10/22/2024$11.99$12.43+3.67%$12.71$11.8774,646 shs$157.87 million10/21/2024$12.22$11.99-1.88%$12.39$11.68102,567 shs$152.29 million10/18/2024$12.09$12.22+1.08%$12.38$11.9129,051 shs$155.21 million10/17/2024$11.84$12.09+2.11%$12.41$11.8975,770 shs$153.56 million10/16/2024$11.92$11.84-0.67%$12.17$11.5660,100 shs$150.38 million10/15/2024$12.30$11.92-3.09%$12.73$11.8371,627 shs$151.40 million10/14/2024$12.15$12.30+1.23%$12.76$11.8791,453 shs$156.22 million10/11/2024$11.93$12.15+1.84%$12.41$11.9135,540 shs$151.63 million10/10/2024$12.19$11.93-2.13%$12.46$11.8839,650 shs$151.52 million10/09/2024$11.92$12.19+2.27%$12.68$11.9557,395 shs$154.83 million10/08/2024$11.68$11.92+2.05%$12.25$11.6050,708 shs$151.40 million10/07/2024$11.40$11.68+2.46%$11.69$11.1877,319 shs$148.35 million10/04/2024$11.41$11.40-0.09%$11.99$11.3858,662 shs$144.79 million10/03/2024$11.49$11.41-0.70%$11.61$11.0492,515 shs$144.92 million10/02/2024$12.33$11.49-6.81%$12.37$11.3997,374 shs$145.93 million10/01/2024$12.08$12.33+2.07%$12.65$11.9881,169 shs$156.60 million09/30/2024$12.98$12.08-6.93%$13.20$11.61154,121 shs$153.43 million09/27/2024$13.19$12.98-1.59%$13.71$12.87139,421 shs$164.86 million09/26/2024$11.85$13.19+11.31%$13.40$12.25213,672 shs$167.53 million09/25/2024$10.88$11.85+8.92%$11.85$10.50167,803 shs$147.89 million09/24/2024$10.47$10.88+3.92%$11.13$10.5362,518 shs$138.19 million09/23/2024$10.78$10.47-2.88%$10.78$10.2499,416 shs$132.98 million09/20/2024$10.30$10.78+4.66%$10.87$10.14118,457 shs$136.92 million09/19/2024$10.14$10.30+1.58%$10.35$10.0256,854 shs$130.82 million09/18/2024$10.00$10.14+1.40%$10.32$9.9578,924 shs$128.79 million09/17/2024$9.93$10.00+0.70%$10.31$9.8873,557 shs$127.01 million09/16/2024$10.50$9.93-5.43%$10.59$9.9177,003 shs$123.93 million09/13/2024$9.75$10.50+7.69%$10.95$9.77199,580 shs$131.04 million09/12/2024$9.41$9.75+3.61%$9.77$9.0095,771 shs$123.84 million09/11/2024$9.59$9.41-1.88%$9.60$9.0070,861 shs$117.44 million09/10/2024$8.53$9.59+12.43%$9.63$8.9472,280 shs$119.68 million09/09/2024$9.77$8.53-12.69%$9.66$8.17149,214 shs$106.45 millionTrue paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.09/06/2024$9.00$9.77+8.56%$10.48$9.06313,966 shs$124.09 million09/05/2024$8.78$9.00+2.51%$9.12$8.64102,264 shs$114.31 million09/04/2024$7.71$8.78+13.88%$8.94$7.6693,160 shs$111.52 million09/03/2024$7.96$7.71-3.14%$8.17$7.28105,632 shs$97.93 million09/02/2024$7.96$7.96$8.01$7.5885,800 shs$101.10 million08/30/2024$7.77$7.96+2.45%$8.01$7.5885,823 shs$101.10 million08/29/2024$8.81$7.77-11.80%$9.14$7.09162,216 shs$98.69 million08/28/2024$8.75$8.81+0.69%$8.99$8.6557,138 shs$111.90 million08/27/2024$8.84$8.75-1.02%$8.91$8.6060,560 shs$111.13 million08/26/2024$8.60$8.84+2.79%$8.95$8.5565,166 shs$112.28 million08/23/2024$8.38$8.60+2.63%$8.63$8.1641,554 shs$109.23 million08/22/2024$8.47$8.38-1.06%$8.60$8.2218,183 shs$106.43 million08/21/2024$8.41$8.47+0.71%$8.73$8.2675,097 shs$107.58 million08/20/2024$8.42$8.41-0.12%$8.71$8.3250,282 shs$106.82 million08/19/2024$8.03$8.42+4.86%$8.48$7.9593,065 shs$106.94 million08/16/2024$8.18$8.03-1.83%$8.38$8.0023,773 shs$101.99 million08/15/2024$8.00$8.18+2.25%$8.35$7.9569,918 shs$103.89 million08/14/2024$8.08$8.00-0.99%$8.21$8.0028,886 shs$101.61 million08/13/2024$7.86$8.08+2.80%$8.32$7.7757,342 shs$102.62 million08/12/2024$7.84$7.86+0.26%$8.19$7.6560,321 shs$99.83 million08/09/2024$7.38$7.84+6.23%$8.00$7.3871,265 shs$99.58 million08/08/2024$7.59$7.38-2.77%$8.10$7.26148,423 shs$93.73 million08/07/2024$7.39$7.59+2.71%$8.00$7.3967,845 shs$96.40 million08/06/2024$7.37$7.39+0.34%$7.49$7.1051,548 shs$93.85 million08/05/2024$8.35$7.37-11.80%$8.20$7.3165,098 shs$93.54 million08/02/2024$8.07$8.35+3.47%$8.57$7.7777,470 shs$106.05 million08/01/2024$8.18$8.07-1.34%$8.40$8.0635,081 shs$102.49 million07/31/2024$8.17$8.18+0.12%$8.32$7.83141,205 shs$103.89 million Related Companies Acelyrin Stock Chart Nuvation Bio Stock Chart Mereo BioPharma Group Stock Chart Exscientia Stock Chart Alumis Stock Chart Aligos Therapeutics Stock Chart Aura Biosciences Stock Chart Q32 Bio Stock Chart Silence Therapeutics Stock Chart Arcturus Therapeutics Stock Chart Receive LFVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LFVN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeVantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.